Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

US Patent 10994010 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →